[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356686-105":59,"doc-detail-356686-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","regulatory-b-cell-related-gene-signature-predicts-prognosis-and-immune-landscape-in-head-and-neck-squamous-cell-carcinoma","Regulatory B cell-related gene signature predicts prognosis and immune landscape in head and neck squamous cell carcinoma","","Regulatory B cells (Bregs) play key roles in immune regulation and tolerance across cancers, yet their contribution to head and neck squamous cell carcinoma (HNSCC) remains unclear. This study constructs and validates a Breg-related prognostic gene signature using TCGA training data and independent TCGA/GEO cohorts. Associations are evaluated with clinicopathological features, immune checkpoint expression, tumor mutation burden, immune infiltration, and drug sensitivity, with mechanisms explored via WGCNA and GSEA, including experimental work on OLR1.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/regulatory-b-cell-related-gene-signature-predicts-prognosis-and-immune-landscape-in-head-and-neck-squamous-cell-carcinoma/356686/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/regulatory-b-cell-related-gene-signature-predicts-prognosis-and-immune-landscape-in-head-and-neck-squamous-cell-carcinoma/356686.png","ImageObject",300,407,{"name":92,"@type":93},"Jordan Avery","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main purpose of this study?","Question",{"text":112,"@type":113},"To develop and validate a Breg-related gene signature that predicts prognosis and characterizes the immune landscape in HNSCC, with potential therapeutic implications.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the prognostic gene signature constructed and validated?",{"text":117,"@type":113},"A TCGA-HNSCC training cohort was used to derive the signature using consensus clustering and Cox regression approaches, then validated in independent TCGA and GEO cohorts to test robustness.",{"name":119,"@type":110,"acceptedAnswer":120},"What clinical and immune features differ between high- and low-risk patients?",{"text":121,"@type":113},"High-risk patients show poorer survival, reduced immune cell infiltration, lower immune molecule expression, and improved prognostic accuracy when integrating the risk score with TMB or clinicopathological features.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356686,1791028537,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":26,"preview_page_count":19,"preview_urls":145},1099523882367,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","TYPE Original Research PUBLISHED 10 April 2026  \nDOI 10.3389/fimmu.2026.1739076  \nOPEN ACCESS  \nEDITED BY  \nNarayana Subramaniam,  \nAster International Institute of Oncology, India  \nREVIEWED BY  \nHaotian Cao,  \nSun Yat-sen Memorial Hospital, China Sen Zhang,  \nFirst Hospital of Shanxi Medical University, China  \n*CORRESPONDENCE  \nFujue Wang  \nwfjﬁ[ghting@163.com](ghting@163.com)[ ](ghting@163.com)Pian Li  \n[385406821@qq.com](385406821@qq.com)[ ](385406821@qq.com)RECEIVED 04 November 2025 REVISED 23 February 2026 ACCEPTED 20 March 2026 PUBLISHED 10 April 2026  \nCITATION  \nHe J, Pang K, Zhou Z, Yang C, Chen Y, He S, Wang F and Li P (2026) Regulatory B cell-related gene signature predicts prognosis and immune landscape in head and neck squamous cell carcinoma.  \nFront. Immunol. 17:1739076 .  \ndoi: 10.3389/fimmu.2026.1739076  \nCOPYRIGHT  \n© 2026 He, Pang, Zhou, Yang, Chen, He, Wang and Li. This is an open-access article distributed under the terms of the  \nCreative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nRegulatory B cell-related gene signature predicts prognosis and immune landscape in head and neck squamous cell carcinoma  \nJunyan He 1, Keling Pang 2, Zhigang Zhou 3, Chaolin Yang 2, Yi Chen 2, Sha He 1, Fujue Wang 4,5,6* and Pian Li 1,2*  \n1 Department of Oncology, The First Afﬁliated Hospital, Hengyang Medical School, University of South China, Hengyang, China, 2 Department of Radiation Oncology, The First Afﬁliated Hospital of Guangxi Medical University, Nanning, China, 3Changde Hospital, Xiangya School of Medicine, Central South University, The First People’s Hospital of Changde City, Changde, China, 4 Department of Hematology, The First Afﬁliated Hospital, Hengyang Medical School, University of South China, Hengyang,  \nHunan, China, 5State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China, 6Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China  \nBackground: Regulatory B cells (Bregs) are critical in regulating immune responses and fostering immune tolerance in various cancers; however, their role in head and neck squamous cell carcinoma (HNSCC) is unclear. This study examined the function of Breg-related genes in HNSCC and their possible prognostic and therapeutic implications.  \nMethods: The Cancer Genome Atlas (TCGA)-HNSCC training cohort was used to establish a prognostic signature for Breg-related genes by applying consensus clustering, univariate Cox regression, least absolute shrinkage and selection operator (LASSO) Cox regression, and multivariate Cox regression analyses. Validation cohorts from the TCGA and Gene Expression Omnibus (GEO) databases were used to assess the robustness of the model. This study investigated the associations among the signature and several clinicopathological features, expression of immune checkpoints, tumor mutation burden (TMB), and sensitivity to pharmacological agents. The underlying mechanisms were examined using weighted gene co-expression network analysis (WGCNA) and gene set enrichment analysis (GSEA) . Additionally, various techniques, including ESTIMATE, were used to assess immune inﬁltration. Functional experiments and transcriptome sequencing were conducted to investigate the role of oxidized low-density lipoprotein receptor 1 (OLR1) gene.  \nResults: The analysis identiﬁed an eight-gene Breg-related prognostic signature that demonstrated robust predictive power across cohorts. High-risk patients exhibited signiﬁcantly poorer survival, reduced immune cell inﬁltration, and lower immune molecule expression. The prognostic accuracy was further impro","cbCaijPVuV24B1oW","https://ap.wps.com/l/cbCaijPVuV24B1oW","pdf",27896239,24,"English","# Background\n# Methods\n## Cohort and signature construction\n## Model validation and association analyses\n## Immune landscape and mechanistic exploration\n# Results\n# Conclusions","[{\"question\":\"What is the main purpose of this study?\",\"answer\":\"To develop and validate a Breg-related gene signature that predicts prognosis and characterizes the immune landscape in HNSCC, with potential therapeutic implications.\"},{\"question\":\"How was the prognostic gene signature constructed and validated?\",\"answer\":\"A TCGA-HNSCC training cohort was used to derive the signature using consensus clustering and Cox regression approaches, then validated in independent TCGA and GEO cohorts to test robustness.\"},{\"question\":\"What clinical and immune features differ between high- and low-risk patients?\",\"answer\":\"High-risk patients show poorer survival, reduced immune cell infiltration, lower immune molecule expression, and improved prognostic accuracy when integrating the risk score with TMB or clinicopathological features.\"}]","Regulatory B cell-related gene signature predicts prognosis and immune landscape in head and neck squamous cell carcinoma | PDF",1790126797,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/557beb192918adcaaae9fe8b6a737f0c.webp",983,1389,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2a244b0d9008cc1838d325c0dd02da80.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a0f99d4caf4e5ae4ff5a42efe6fc9055.webp",981,1386,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5021aef44b30158bf434c57b9651999f.webp",980,1385]